Eli Lilly and Company / AMC-Industry Partnerships / Lilly Endowment Inc. / Dole / Academic-Industry Partnerships / /
Continent
America / Europe / /
Country
United States / China / India / /
Currency
USD / /
Event
FDA Phase / /
IndustryTerm
biotechnology firms / technology transfer officers / grant applications / biopharmaceutical industry / manufacturing processes / ideas or products / healthcare innovations / healthcare environment / market-directed health care applications / biopharmaceutical / medical products / university infrastructure / manufacturing / technology platforms / technology transfer offices / biopharmaceutical sponsors / /
MedicalCondition
disease / Parkinson’s disease / diseases / /
MedicalTreatment
Surgery / Radiation / /
NaturalFeature
Region West Coast / West Coast / /
Organization
National Institute of Health / American Association of Medical Colleges / National Science Foundation / Lilly Endowment / Congress / Massachusetts Biology Council / Coalition Against Major Diseases / European Commission / FDA / Tufts University School of Medicine / Research Analyst Tufts Center for the Study of Drug Development / Tufts Center for the Study of Drug Development / /
Person
Ashley Malins / Christopher-Paul Milne / Grant Types / /
Position
principal investigator / consultant / scientist / Director / Executive / representative / /
Product
FY / drug / /
ProvinceOrState
Texas / New Jersey / Vermont / Ohio / Virginia / Alabama / Maryland / Illinois / Indiana / New York / Connecticut / Washington / Michigan / New Mexico / Pennsylvania / Mississippi / Delaware / North Carolina / California / Georgia / Iowa / Arizona / Massachusetts / Colorado / /
Academic-Industry Partnerships for Biopharmaceutical Research & Development: Advancing Medical Science in the U.S. Christopher-Paul Milne, Associate Director Ashley Malins, Research Analyst